Most Recent

image: The Celiac Surge

The Celiac Surge

By Catherine Offord | June 1, 2017

A rapid increase in the global incidence of the condition has researchers scrambling to understand the causes of the trend, and cope with the consequences.

4 Comments

image: Polio Vaccine Pioneer Dies

Polio Vaccine Pioneer Dies

By Kerry Grens | May 2, 2017

Julius Youngner collaborated with Jonas Salk on the polio vaccine, and later identified interferon gamma and contributed to an equine influenza vaccine.

0 Comments

The 19th century biologist’s drawings, tainted by scandal, helped bolster, then later dismiss, his biogenetic law.

3 Comments

Time-lapse imaging shows the immune cells transferring chemical signals during pigment pattern formation in developing zebrafish.

0 Comments

image: Infographic: How the Zebrafish Got Its Stripes

Infographic: How the Zebrafish Got Its Stripes

By Catherine Offord | May 1, 2017

Immune cells called macrophages shuttle cellular messages in the skin.

0 Comments

The lungs of extremely premature lambs supported in a closed, sterile environment that enables fluid-based gas exchange grow and develop normally, researchers report.

0 Comments

image: Image of the Day: Stop Signals

Image of the Day: Stop Signals

By The Scientist Staff | April 17, 2017

Transcytosis, suppression of vesicle traffic across cells, helps reduce permeability in the blood-retinal barrier during development.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By Anna Azvolinsky | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By Rachel Berkowitz | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By Catherine Offord | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Popular Now

  1. Sci-Hub Loses Domains and Access to Some Web Services
  2. Stem Cell Vaccine Protects Mice From Cancer
  3. Nobel Prize–Winning Biologist Dies
  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS